HIV

A study suggests that antiretroviral therapy has benefits even in patients who do not show a virologic or immunologic response.

The race is on to develop a topical preventive agent for reducing the transmission of HIV. Researchers at the University of Texas report in vitro efficacy of a vaginal cream containing silver nanoparticles. Other researchers are already reporting favorable results in human studies of an antiretroviral-containing gel.

Most patients receiving antiretroviral therapy do not meet the minimum threshold for medication adherence, but patients on single-tablet medication regimens tended to meet that threshold.

Saliva tests for detecting anti–hepatitis C antibodies may not be as effective in patients who also have an HIV infection.

An immunotoxin code-named 3B3-PE38 may help shut down HIV-infected cells, according to researchers reporting results of a trial in 40 humanized mice.

A testing program that screens for HIV when patients have indicator disease can catch the virus early, but should be coupled with patient education.

FIT biotech, a Finnish company, expects to begin clinical trials of a vaccine for HIV-infected patients in 2014.

An HIV-infected baby treated aggressively with antiretroviral therapy starting shortly after birth remains virus-free at the age of 3 years despite having ceased treatment at the age of 18 months.

HIV positive patients who become distressed more easily may be less likely to adhere to antiretroviral treatment (ART), suggest the results of a study appearing in the September 2013 edition of Behavior Therapy.

Pharmacists are in a pivotal position to help patients select and properly use at-home test and monitor kits.

A program in which high-risk individuals were offered HIV testing and follow-up support at community pharmacies produced high rates of participation and satisfaction.

This award honors a pharmacist who is improving the future standard of pharmacy practice through his or her professional practice or through advocacy in the pharmacy industry.

Investigators in Spain have identified a relationship between higher-complexity medication regimens and a lower likelihood of sustained viral response (SVR) after treatment for hepatitis C virus (HCV) infection.

In a new study published in the Journal of Managed Care Pharmacy, investigators interviewed patients and pharmacists about the costs and benefits of obtaining antiretroviral therapies from a community pharmacy.

The FDA approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection.

Community pharmacists interviewed for a recently published study were eager to play a role in counseling patients who use over-the-counter HIV tests.

Community pharmacists interviewed for a recently published study were eager to play a role in counseling patients who use over-the-counter HIV tests.

A new study released by the Tufts Center for the Study of Drug Development reports that annual drug approvals for neglected diseases have nearly doubled since 2000, and patient access to these therapies has improved markedly.

Armada Health Care announced today that the AIDS Healthcare Foundation (AHF) has chosen Armada to be its primary purchasing partner.

A study assessing HIV treatment interruption in 14 French subjects suggests that early initiation of antiretroviral therapy may be associated with sustained virological remission.